NorthWest Biotherapeutics Inc (NWBO)

[Pyrrhonian]

Are you guys going to learn from the Rintega failure and apply it to the risk:reward assessment of DCVax-L or no? Are you going to look upon the historical control comparisons with DCVax-L treated patients with a bit more consternation, or just find excuses for why Rintega failed but DCVax-L won't (some placebo activity nonsense, etc)?

ICT-107 was better than matched historical controls. Failed a randomized test. AV0113 (a WTL loaded DC vaccine) was better than matched historical controls. Failed a randomized test. Rintega was better than matched historical controls. Failed a randomized test. DCVax-L treated patients did better than matched controls...

Nope, not gonna consider it even? Okay.

Still only ONE cancer vaccine out of dozens of tries that succeeded in a P3 (after the SECOND try).

The odds are stacked.

GL